Living with Type 2 diabetes can feel overwhelming—but understanding how your medication works can make your treatment plan easier to navigate. In this video, we take a closer look at Ozempic® (semaglutide) and its role in the treatment of Type 2 diabetes. You’ll learn: • What Type 2 diabetes actually does inside the body • Why high blood sugar can affect your blood vessels, nerves, kidneys, eyes, and other organs • What Ozempic (semaglutide) is and how it works • How GLP-1 receptor agonists affect blood sugar • How semaglutide influences insulin and glucagon • Why Ozempic can slow stomach emptying and reduce appetite • Why weight changes can occur while taking semaglutide • Why taking diabetes medication consistently can matter • Why you should talk with your healthcare provider before stopping Ozempic • Important questions to ask your doctor or pharmacist about your medication For certain adults with Type 2 diabetes, Ozempic is indicated to reduce the risk of major cardiovascular events, including heart attack, stroke, or cardiovascular death. Current prescribing information also includes an indication for reducing the risk of sustained kidney function decline, end-stage kidney disease, and cardiovascular death in adults with Type 2 diabetes and chronic kidney disease. Most importantly, if you have questions about your medication—whether it's the dose, side effects, missed doses, cost, injections, or stopping treatment—talk with your healthcare provider or pharmacist. Your treatment plan should be something you understand, not something you simply follow blindly. Subscribe to Rehealthify for clear, evidence-based health education about diabetes, medications, symptoms, and the science behind your health. IMPORTANT EDUCATIONAL DISCLAIMER This video is for general educational and informational purposes only and is not medical advice. It is not intended to diagnose, treat, cure, or prevent any disease or condition. Medication decisions should be made with a qualified healthcare professional who knows your individual medical history. Do not start, stop, or change any medication without first speaking with your healthcare provider or pharmacist. Ozempic® is a registered trademark of Novo Nordisk. Rehealthify is not affiliated with or endorsed by Novo Nordisk. Sources: U.S. Food and Drug Administration (FDA), Ozempic® (semaglutide) Prescribing Information. National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK), Type 2 Diabetes information.